These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 23667648)
1. Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts. Shimmura-Tomita M; Wang M; Taniguchi H; Akiba H; Yagita H; Hori J PLoS One; 2013; 8(5):e63620. PubMed ID: 23667648 [TBL] [Abstract][Full Text] [Related]
2. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517 [TBL] [Abstract][Full Text] [Related]
3. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege. Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569 [TBL] [Abstract][Full Text] [Related]
4. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege. Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558 [TBL] [Abstract][Full Text] [Related]
5. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells. Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125 [TBL] [Abstract][Full Text] [Related]
6. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954 [TBL] [Abstract][Full Text] [Related]
8. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice. Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782 [TBL] [Abstract][Full Text] [Related]
9. Two different regulatory T cell populations that promote corneal allograft survival. Cunnusamy K; Paunicka K; Reyes N; Yang W; Chen PW; Niederkorn JY Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6566-74. PubMed ID: 20702818 [TBL] [Abstract][Full Text] [Related]
10. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Wang F; He W; Yuan J; Wu K; Zhou H; Zhang W; Chen ZK Transpl Immunol; 2008 Apr; 19(1):12-9. PubMed ID: 18346632 [TBL] [Abstract][Full Text] [Related]
11. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414 [TBL] [Abstract][Full Text] [Related]
13. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W; Xie L; Wang S Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993 [TBL] [Abstract][Full Text] [Related]
14. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Yamada J; Kurimoto I; Streilein JW Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657 [TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival. Niederkorn JY; Mayhew E; Mellon J; Hegde S Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491 [TBL] [Abstract][Full Text] [Related]